Viewing Study NCT06034561


Ignite Creation Date: 2025-12-24 @ 12:21 PM
Ignite Modification Date: 2026-01-20 @ 1:04 AM
Study NCT ID: NCT06034561
Status: RECRUITING
Last Update Posted: 2025-05-16
First Post: 2023-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia
Sponsor: Instituto do Cancer do Estado de São Paulo
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module